| SOLVENTUM CORP. DL-,01 |
| USA |
| Gesundheit |
| US83444M1018 / A407ZE |
| KB7 (Frankfurt) / SOLV (NYSE) |
| FRA:KB7, ETR:KB7, KB7:GR, NYSE:SOLV |
| - |
| https://www.solventum.com.. |
|
Solventum Corporation is a leading American healthcare company that emerged as an independent entity following its spin-off from 3M in April 2024. Built on over 70 years of healthcare innovation, Solventum develops, manufactures, and commercializes s..
>Volltext.. |
| 9671.77 Mio. EUR |
| 13389.93 Mio. EUR |
| 7231.13 Mio. EUR |
| 1318.53 Mio. EUR |
| 1347.99 Mio. EUR |
| 7.74 EUR |
| 4545.55 Mio. EUR |
| 760.62 Mio. EUR |
| 319.67 Mio. EUR |
| 0.28 |
| -10.86% |
| 186.92% |
| - |
| - |
| - |
| SOLVENTUM |
| 05.04.26 |
|
||||
|
||||
|